{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T00:30:20Z","timestamp":1713659420857},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,4,15]]},"DOI":"10.2169\/internalmedicine.2384-23","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T22:16:43Z","timestamp":1713133003000},"page":"1163-1166","source":"Crossref","is-referenced-by-count":0,"title":["Blepharoptosis As an Early Manifestation of Neuronal Intranuclear Inclusion Disease"],"prefix":"10.2169","volume":"63","author":[{"given":"Noriyuki","family":"Miyaue","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko H.","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Sone J, Tanaka F, Koike H, et al. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology 76: 1372-1376, 2011.","DOI":"10.1212\/WNL.0b013e3182166e13"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sone J, Mitsuhashi S, Fujita A, et al. Long-read sequencing identifies GGC repeat expansions in <i>NOTCH2NLC<\/i> associated with neuronal intranuclear inclusion disease. Nat Genet 51: 1215-1221, 2019.","DOI":"10.1038\/s41588-019-0459-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tian Y, Zhou L, Gao J, et al. Clinical features of <i>NOTCH2NLC<\/i>-related neuronal intranuclear inclusion disease. J Neurol Neurosurg Psychiatry 93: 1289-1298, 2022.","DOI":"10.1136\/jnnp-2022-329772"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hayashi K, Hamaguchi T, Sakai K, et al. Neuronal intranuclear inclusion disease showing blepharoptosis and positive serum anti-acetylcholine receptor antibody without myasthenia gravis. J Neurol Sci 400: 119-121, 2019.","DOI":"10.1016\/j.jns.2019.03.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hashemi H, Khabazkhoob M, Emamian MH, et al. The prevalence of ptosis in an Iranian adult population. J Curr Ophthalmol 28: 142-145, 2016.","DOI":"10.1016\/j.joco.2016.04.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ogasawara M, Iida A, Kumutpongpanich T, et al. CGG expansion in <i>NOTCH2NLC<\/i> is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun 8: 204, 2020.","DOI":"10.1186\/s40478-020-01084-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Danesh-Meyer HV, Savino P, Sergott R. The correlation of phenylephrine 1% with hydroxyamphetamine 1% in Horner&apos;s syndrome. Br J Ophthalmol 88: 592-593, 2004.","DOI":"10.1136\/bjo.2003.029371"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tachi K, Takata T, Kume K, et al. Long-term MRI findings of adult-onset neuronal intranuclear inclusion disease. Clin Neurol Neurosurg 201: 106456, 2021.","DOI":"10.1016\/j.clineuro.2020.106456"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tai H, Wang A, Zhang Y, et al. Clinical features and classification of neuronal intranuclear inclusion disease. Neurol Genet 9: e200057, 2023.","DOI":"10.1212\/NXG.0000000000200057"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Norcliffe-Kaufmann L, Kaufmann H, Palma JA, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 83: 522-531, 2018.","DOI":"10.1002\/ana.25170"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/8\/63_2384-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T03:30:58Z","timestamp":1713583858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/8\/63_2384-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2384-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"article-number":"2384-23"}}